Evaxion Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	20	19	41	85	-	-	-
Market Cap Growth	-	-53.98%	-51.46%	-	-	-	-
Enterprise Value	26	24	38	56	-6	-10	1
PE Ratio	-0.86	-0.86	-1.78	-3.46	-	-	-
PS Ratio	277.90	259.63	-	-	-	-	-
PB Ratio	-4.01	-4.01	4.96	2.62	-	-	-
P/FCF Ratio	-1.07	-1.07	-1.58	-3.64	-	-	-
P/OCF Ratio	-1.07	-1.07	-1.60	-3.87	-	-	-
EV/Sales Ratio	350.32	332.05	-	-	-	-	-
EV/EBITDA Ratio	-1.14	-1.14	-1.71	-2.37	0.36	0.88	-0.22
EV/EBIT Ratio	-1.14	-1.14	-1.71	-2.37	0.36	0.88	-0.22
EV/FCF Ratio	-1.36	-1.36	-1.47	-2.42	0.46	1.35	-0.62
Debt / Equity Ratio	-2.30	-2.30	1.24	0.11	0.00	0.00	-9.31
Debt / EBITDA Ratio	-0.51	-0.51	-0.46	-0.16	0.00	0.00	-1.56
Debt / FCF Ratio	-0.61	-0.61	-0.39	-0.16	0.00	-0.01	-4.34
Quick Ratio	1.06	1.06	4.25	7.70	1.50	5.89	0.81
Current Ratio	1.18	1.18	4.51	8.03	2.22	6.36	0.89
Asset Turnover	0.00	0.00	0	0	0	0	0
Interest Coverage	-12.63	-12.63	-14.88	-26.01	-73.33	-8.84	-7.72
Return on Equity (ROE)	-1238.10%	-1238.10%	-113.70%	-99.40%	-183.10%	-265.60%	-683.80%
Return on Assets (ROA)	-126.70%	-126.70%	-74.50%	-77.40%	-130.30%	-114.30%	-96.60%
Return on Capital (ROIC)	-361.46%	-361.46%	-136.14%	-71.51%	-234.74%	-115.59%	-72.73%
Earnings Yield	-109.06%	-116.74%	-56.25%	-28.91%	-	-	-
FCF Yield	-87.63%	-93.80%	-63.29%	-27.45%	-	-	-
Buyback Yield / Dilution	-19.12%	-19.12%	-20.86%	-1.32%	-	-	-
Total Shareholder Return	-19.12%	-19.12%	-20.86%	-1.32%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).